Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 25, 2018 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis to Present at OTCQX Virtual Investor Conference for Domestic Companies

ST. LOUIS, Mo., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced...
August 07, 2018 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Reports 2018 Second Quarter Financial Results

Progress on strategic internal innovation and external collaborationsContinued growth in recurring revenuePositive cash flow from operationsReaffirming 2018 expectationsConference call today at 10:00...
July 31, 2018 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis to Report Second Quarter 2018 Financial Results on August 7, 2018

ST. LOUIS, July 31, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it...
June 25, 2018 08:30 ET | Source: Stereotaxis, Inc.

Stereotaxis and Johnson & Johnson’s Biosense Webster Extend Development Alliance and Supply Agreement

ST. LOUIS, June 25, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that it...
June 04, 2018 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Announces Changes to its Board of Directors

ST. LOUIS, June 04, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the...
May 22, 2018 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis to Present at 8th Annual LD Micro Invitational

ST. LOUIS, May 22, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David...
May 14, 2018 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Reports 2018 First Quarter Financial Results

3% year-over-year growth in recurring revenueContinued progress on strategic innovation initiatives; collaboration with Acutus MedicalIncreasing quantity and quality of peer-reviewed clinical...
May 04, 2018 09:05 ET | Source: Stereotaxis, Inc.

Stereotaxis to Highlight Unique Advantages of Robotic Cardiac Ablation at Heart Rhythm 2018

ST. LOUIS, May 04, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that it...
May 04, 2018 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis to Report First Quarter 2018 Financial Results on May 14, 2018

ST. LOUIS, May 04, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it...
May 03, 2018 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis and Acutus Medical Announce Strategic Collaboration

Formal testing supports joint use of the two systemsPositive initial clinical experience demonstrates additive benefits of technologiesCommitment to robust integration of technologies to enhance...